Share this article
Share this article
WASHINGTON, May 12, 2021 /PRNewswire/ MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity, is pleased to announce its role in the successful management and execution of Simplify Medical s two clinical studies and approvals by the U.S. Food and Drug Administration (FDA) for the Simplify Cervical Artificial Disc (Simplify Disc) to be used at one-level and two contiguous levels in the cervical spine.
Abigail Allen, MCRA s Vice President of Clinical Affairs, said, MCRA is honored to have supported Simplify Medical with the approval of their two-level disc just six months after the one-level approval. It has been a true testament to the teamwork and collaboration between the two companies, and all of our sites, to get the
Share this article
Share this article
SAN DIEGO, April 6, 2021 /PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify
® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR). This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio, said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. There is immense surgeon excitement for this latest edition to our cervical offering, and the expanded two-level indication provides greater opportunities to bring the most clinically effective technology in the cTDR market to more patients.
NuVasive s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results Acquires Simplify Medical and the most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment Submits 510(k) clearance for Pulse platform and reiterates summer 2021 launch Continued to increase R&D investments in 2020 to advance Company s innovation roadmap Delivered strong Q4 2020 international growth
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 25, 2021 /PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2020.
NuVasive Acquires Simplify Medical
Simplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment
Expands growth opportunities and further differentiates Company s comprehensive portfolio across ACDF, PCF, and cTDR procedures
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 24, 2021 /PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify
® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).